We are also exploring ways to activate the natural T-cell response to attack cancer cells, through the development of next-generation immune engagers with potential in hard-to-treat solid tumours.
We are also exploring ways to activate the natural T-cell response to attack cancer cells, through the development of next-generation immune engagers with potential in hard-to-treat solid tumours. T-cell engagers have one arm that binds to T-cells and another that binds to cancer cells, and thus ‘pull’ T-cells into the tumour.